Maprotiline Hydrochloride

CHEMBL1237135 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

313.9 g/mol

LogP

—

Phase

4

A hydrochloride salt form of maprotiline, a tetracyclic antidepressant used to treat depression and anxiety by increasing norepinephrine activity in the brain.

Moleküler Ağırlık

313,9000 g/mol

TPSA

12,00 Å²

Terapötik Alanlar

Schizophrenia Generalized Anxiety Disorder

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

CNCCCC12CCC(c3ccccc31)c1ccccc12.Cl

InChI

InChI=1S/C20H23N.ClH/c1-21-14-6-12-20-13-11-15(16-7-2-4-9-18(16)20)17-8-3-5-10-19(17)20;/h2-5,7-10,15,21H,6,11-14H2,1H3;1H

Molecular Formula

C20H24ClN

HBD / HBA

2 / 1

Döndürülebilir Bağlar

4

Ağır Atomlar

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A hydrochloride salt form of maprotiline, a tetracyclic antidepressant used to treat depression and anxiety by increasing norepinephrine activity in the brain.

Yes, Maprotiline Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1237135. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 71478. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Maprotiline Hydrochloride PillFYI'da

Yapı

Hızlı Veriler

Formül: C20H24ClN

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.